ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 220,48
-0,81%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) Actualités

AVDL Avadel Pharmaceuticals PLC

17,81
-0,01 (-0,06%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Avadel Pharmaceuticals PLC AVDL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,01 -0,06% 17,81 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
17,85 17,71 18,22 17,81 17,82
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/4/202414:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
05/3/202414:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
04/3/202421:51EDGAR2Form 8-K - Current report
04/3/202421:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
04/3/202412:35EDGAR2Form 8-K - Current report
04/3/202412:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
04/3/202412:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202414:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
14/2/202413:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
16/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:20EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
29/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202320:54EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202313:09EDGAR2Form 8-K - Current report
08/11/202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
07/11/202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
30/10/202313:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/10/202314:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
05/10/202314:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
02/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202314:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
15/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202321:50EDGAR2Form 144 - Report of proposed sale of securities
11/8/202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:37EDGAR2Form 8-K - Current report
09/8/202313:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
03/8/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:15EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
03/8/202313:30EDGAR2Form 8-K - Current report
02/8/202314:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
20/7/202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
06/7/202322:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..

Dernières Valeurs Consultées

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés